Discovery of 1-( 4-( 4-Propionylpiperazin-1-yl )-3-( trifluoromethyl ) phenyl )-9-( quinolin-3-yl ) benzo [ h ] [ 1 , 6 ] naphthyridin-2 ( 1 H )-one as a Highly Potent
Discovery of 1-( 4-( 4-Propionylpiperazin-1-yl )-3-( trifluoromethyl ) phenyl )-9-( quinolin-3-yl ) benzo [ h ] [ 1 , 6 ] naphthyridin-2 ( 1 H )-one as a Highly Potent
复制标题
1-( 4-( 4-丙酰哌嗪-1-基 )-3-( 三氟甲基 ) 苯基 )-9-( 喹啉-3-基 ) 苯并 [ h ] [ 1 , 6 ] naphthyridin-2 ( 1 H ) 的发现
DOI:
--
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
N. Gray
中科院分区:
文献类型:
--
作者:
Qingsong Liu;J. Chang;Jun Wang;S. A. Kang;Catie Carson;Thoreen;Andrew L. Markhard;W. Hur;Jianming Zhang;Taebo Sim;David A. Mortensen;M. H. Sabatini;N. Gray
The mTOR protein is a master regulator of cell growth and proliferation, and inhibitors of its kinase activity have the potential to become new class of anti-cancer drugs. Starting from quinoline 1, which was identified in a biochemical mTOR assay, we developed a tricyclic benzonaphthyridinone inhibitor Torin1(26), which inhibited phosphorylation of mTORC1 and mTORC2 substrates in cells at concentrations of 2 nM and 10 nM, respectively. Moreover, Torin1 exhibits 1000-fold selectivity for mTOR over PI3K (EC50 = 1800 nM) and exhibits 100-fold binding selectivity relative to 450 other protein kinases. Torin1 was efficacious at a dose of 20 mg/ kg in a U87MG xenograft model, and demonstrated good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues. These results demonstrate that Torin1 is a useful probe of mTOR-dependent phenomena and that benzonaphthridinones represent a promising scaffold for the further development of mTOR-specific inhibitors with the potential for clinical utility.
DOI:
10.1073/pnas.95.25.14950
发表时间:
1998-12-08
影响因子:
11.1
作者:
Aoki, M;Batista, O;Vogt, PK
通讯作者:
Vogt, PK
影响因子:
16
作者:
Yip CK;Murata K;Walz T;Sabatini DM;Kang SA
通讯作者:
Kang SA
影响因子:
16
作者:
Sarbassov, DD;Ali, SM;Sabatini, DM
通讯作者:
Sabatini, DM